Atinary Technologies Inc. enters a collaboration agreement with Parithera. This collaboration aims to leverage and augment the capabilities of Parithera’s researchers with Atinary’s self-driving labs, machine learning algorithms and cloud-based software platform.

Specifically, Parithera will use Atinary’s ML data-driven experiment planning technology to accelerate the development of its single-cell sequencing platform. We are proud to witness this collaboration between two Biopôle residents that aims to save lives by introducing revolutionary diagnostics for cancer treatment resistance.